- Home
- MOLN vs NEOV Comparison
MOLN vs NEOV Comparison
Compare MOLN & NEOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- NEOV
- Stock Information
- Founded
- MOLN 2004
- NEOV 2018
- Country
- MOLN Switzerland
- NEOV United States
- Employees
- MOLN N/A
- NEOV N/A
- Industry
- MOLN
- NEOV Industrial Machinery/Components
- Sector
- MOLN
- NEOV Miscellaneous
- Exchange
- MOLN Nasdaq
- NEOV Nasdaq
- Market Cap
- MOLN 195.4M
- NEOV 181.8M
- IPO Year
- MOLN 2021
- NEOV N/A
- Fundamental
- Price
- MOLN $5.30
- NEOV $3.79
- Analyst Decision
- MOLN
- NEOV Strong Buy
- Analyst Count
- MOLN 0
- NEOV 1
- Target Price
- MOLN N/A
- NEOV $7.50
- AVG Volume (30 Days)
- MOLN 7.1K
- NEOV 303.3K
- Earning Date
- MOLN 03-13-2025
- NEOV 02-07-2025
- Dividend Yield
- MOLN N/A
- NEOV N/A
- EPS Growth
- MOLN N/A
- NEOV N/A
- EPS
- MOLN N/A
- NEOV N/A
- Revenue
- MOLN $7,105,397.00
- NEOV $2,471,178.00
- Revenue This Year
- MOLN N/A
- NEOV $85.10
- Revenue Next Year
- MOLN $29.41
- NEOV $281.25
- P/E Ratio
- MOLN N/A
- NEOV N/A
- Revenue Growth
- MOLN N/A
- NEOV N/A
- 52 Week Low
- MOLN $3.32
- NEOV $0.63
- 52 Week High
- MOLN $12.70
- NEOV $6.11
- Technical
- Relative Strength Index (RSI)
- MOLN 48.54
- NEOV 36.89
- Support Level
- MOLN $4.98
- NEOV $3.98
- Resistance Level
- MOLN $5.91
- NEOV $4.75
- Average True Range (ATR)
- MOLN 0.27
- NEOV 0.50
- MACD
- MOLN 0.05
- NEOV -0.13
- Stochastic Oscillator
- MOLN 47.50
- NEOV 4.21
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.